SAB Biotherapeutics, Inc.SAB Biotherapeutics, Inc.SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc.

No trades
See on Supercharts

Price target

15.500.00 0.00%
The 2 analysts offering 1 year price forecasts for SABS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to SABS in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

SABS EPS for the last quarter is −3.38 USD despite the estimation of −0.62 USD. In the next quarter EPS is expected to reach −0.96 USD. Track more of SAB Biotherapeutics, Inc. financials and stay on top of what is up with the company.
According to analysts, SABS price target is 15.50 USD with a max estimate of 25.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with SABS news and stock market news.